Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.35 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16287335 | 0.86 | CYP4F2 (0.36) | AKT1TSHRALDH1A1LMNAALOX5 | |
| SCHEMBL16289139 | 0.86 | AKT1 (0.44) | AKT1TSHRALDH1A1LMNAEPHX2 | |
| SCHEMBL16289224 | 0.83 | — | — | |
| SCHEMBL2401509 | 0.80 | TSHR (0.63) | AKT1TSHRALDH1A1LMNAEPHX2 | |
| SCHEMBL9188658 | 0.80 | TSHR (0.63) | AKT1TSHRALDH1A1LMNAEPHX2 | |
| SCHEMBL2401513 | 0.80 | TSHR (0.63) | AKT1TSHRALDH1A1LMNAEPHX2 | |
| SCHEMBL16288357 | 0.79 | TSHR (0.54) | TSHRALDH1A1LMNAEPHX2ALOX5 | |
| SCHEMBL16287732 | 0.79 | AKT1 (0.44) | AKT1TSHRALDH1A1LMNAEPHX2 | |
| SCHEMBL16289005 | 0.78 | TSHR (0.52) | TSHRALDH1A1LMNAEPHX2KMT2A | |
| SCHEMBL16287316 | 0.76 | HCAR2 (0.43) | AKT1ALDH1A1KMT2AMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150045409-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-12 | — | — | US | disclosed |
| EP-2813493-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | Sumitomo Chemical Company Limited (JP) | 2014-12-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045409-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | ARG1, ACOT7, RPS8 | AKT1 811/4885TSHR 216/4885ALDH1A1 3183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.